ipsc-drug discovery

amyotrophic lateral sclerosis ctcae, common terminology criteria for adverse events crp, c-reactive protein %fvc, forced vital capacity 6-ohda, 6-hydroxydopamine 8-ohdg, 8-hydroxydeoxyguanosine adr, adverse reaction ae, adverse effect alp, alkaline phosphatase als, amyotrophic lateral sclerosis alsaq-40, amyotrophic lateral sclerosis assessment questionnaire-40 alsfrs-r, als functional rating scale-revised alt, alanine aminotransferase aptt, activated partial thromboplastin time ast, aspartate aminotransferase bun, blood urea nitrogen cafs, combined assessment of function and survival ck, creatine kinase cpk, creatine phosphokinase edc, electronic data capture